A detailed history of State Of New Jersey Common Pension Fund D transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 35,673 shares of ITCI stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,673
Previous 35,450 0.63%
Holding current value
$3.09 Million
Previous $2.43 Million 7.46%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$67.99 - $80.84 $15,161 - $18,027
223 Added 0.63%
35,673 $2.61 Million
Q2 2024

Aug 07, 2024

SELL
$64.76 - $79.84 $1.1 Million - $1.36 Million
-16,972 Reduced 32.38%
35,450 $2.43 Million
Q3 2023

Nov 08, 2023

SELL
$52.09 - $64.1 $156,738 - $192,876
-3,009 Reduced 5.43%
52,422 $2.73 Million
Q4 2022

Feb 01, 2023

BUY
$44.07 - $54.45 $106,693 - $131,823
2,421 Added 4.57%
55,431 $2.93 Million
Q1 2022

May 03, 2022

SELL
$38.74 - $62.09 $647,655 - $1.04 Million
-16,718 Reduced 23.98%
53,010 $3.24 Million
Q4 2021

Jan 31, 2022

SELL
$35.2 - $53.42 $772,428 - $1.17 Million
-21,944 Reduced 23.94%
69,728 $3.65 Million
Q3 2021

Oct 27, 2021

BUY
$28.72 - $42.49 $720,469 - $1.07 Million
25,086 Added 37.67%
91,672 $3.42 Million
Q2 2021

Jul 23, 2021

BUY
$29.3 - $44.5 $83,299 - $126,513
2,843 Added 4.46%
66,586 $2.72 Million
Q1 2021

Apr 27, 2021

SELL
$30.8 - $39.51 $566,412 - $726,588
-18,390 Reduced 22.39%
63,743 $2.16 Million
Q4 2020

Feb 03, 2021

BUY
$23.34 - $32.22 $1.92 Million - $2.65 Million
82,133 New
82,133 $2.61 Million
Q3 2020

Oct 27, 2020

SELL
$17.61 - $31.86 $1.48 Million - $2.67 Million
-83,840 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$14.35 - $26.64 $1.2 Million - $2.23 Million
83,840 New
83,840 $2.15 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.17B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.